Glenmark is a research-led, global pharmaceutical company, driven by a vision to create ‘A new way for a new world’. Founded in 1977, we have a presence in over 80 countries in Branded, Generics, and OTC segments, with a primary focus on therapeutic areas of respiratory, dermatology and oncology, and also a regional presence in areas like diabetes, cardiovascular and oral contraceptives. Our talented team of over 15,000 employees are dedicated to our commitment of harnessing the potential of innovation while challenging established treatment paradigms, to unlock greater value and make a difference in the lives of our patients.